Immix Historical Valuation

IMMX Stock  USD 1.94  0.03  1.52%   
Some fundamental drivers such as market cap or Immix Biopharma enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Immix Biopharma valuation indicators such as Enterprise Value of 28.8 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Immix Biopharma's future value.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.

About Immix Valuation Data Analysis

Valuation is the financial process of determining what Immix Biopharma is worth. Immix Biopharma valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Immix Biopharma valuation ratios help investors to determine whether Immix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Immix with respect to the benefits of owning Immix Biopharma security.

Immix Biopharma Valuation Data Chart

Market Cap is likely to rise to about 28.2 M in 2025. Enterprise Value is likely to rise to about 28.8 M in 2025

Enterprise Value

Enterprise Value (or EV) is usually referred to as Immix Biopharma theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Immix Biopharma debt, but would also pocket its cash. Enterprise Value is more accurate representation of Immix Biopharma value than its market capitalization because it takes into account all of Immix Biopharma existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.